Clinical Trials

Bladder Cancer Trials

Prostate, Urinary BladderA Phase 1, First-in-Human, Dose-Escalation and Expansion Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
Urinary BladderA Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer (VOLGA)Principal Investigator: Daniel P. Petrylak
Other Urinary, Urinary BladderPhase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer After Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based ImmunotherapyPrincipal Investigator: Daniel P. Petrylak

Prostate Cancer Trials

ProstatePRISM: Patient Experiences with PET Imaging in Prostate Cancer
Prostate, Urinary BladderA Phase 1, First-in-Human, Dose-Escalation and Expansion Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
ProstateA Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate CancerPrincipal Investigator: Daniel P. Petrylak
ProstateParallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)Principal Investigator: Yi An
ProstateA Phase 1/2 Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate CancerPrincipal Investigator: Joseph Kim

Kidney Cancer Trials

Kidney, Melanoma, SkinXTX301 in Patients With Advanced Solid Tumors
KidneyPhase II Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell CarcinomaPrincipal Investigator: Kimberly L. Johung
Kidney, Melanoma, skinA Multicenter Phase 2 Trial to Evaluate Intracranial Response to Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma Who Are Anti-PD1/PD-L1 ExperiencedPrincipal Investigator: Harriet Kluger

Kidney & Urinary Tract Trials

Diseases of the Kidney & Urinary TractTreating Kidney Disease in Patients with APOL1
Children's Health, Diseases of the Kidney & Urinary TractComparison of smart bedwetting alarm vs standard bedwetting alarm

All Urology Trials

ProstatePRISM: Patient Experiences with PET Imaging in Prostate Cancer
Prostate, Urinary BladderA Phase 1, First-in-Human, Dose-Escalation and Expansion Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
Kidney, Melanoma, SkinXTX301 in Patients With Advanced Solid Tumors
Urinary BladderA Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer (VOLGA)Principal Investigator: Daniel P. Petrylak
ProstateA Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 509 in Subjects With Metastatic Castration-Resistant Prostate CancerPrincipal Investigator: Daniel P. Petrylak